Aphria, Inc. (NYSE: APHA)
Hagens Berman Sobol Shapiro LLP reminds investors in Aphria, Inc. (NYSE: APHA) of the February 4, 2019 Lead Plaintiff deadline in the securities class action pending in the U.S. District Court for the Southern District of New York.
If you purchased or otherwise acquired shares of APHA between July 17, 2015 and Dec. 4, 2018 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information, contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing APHA@hbsslaw.com.
On November 2, 2018, Aphria began trading on the NYSE at $11.75 per share. About one month later, on December 3, 2018, several media sources began reporting that Aphria has been diverting shareholder assets to insiders through an elaborate “shell game” scheme using international shell companies to stage unusual acquisitions by foreign entities, essentially leaving Aphria’s shareholders holding the bag with shares backed by worthless assets.
There have also been reports that Aphria generates negative cash, and that its cannabis facilities were allegedly infested with bugs, stricken with mold, and have failed audit inspections.
This news drove the price of Aphria shares down 23.42% to close at $6.05 on December 3, 2018, a 51% drop YTD.
Then, on January 11, 2019, the Company announced CEO Vic Neufeld and Co-founder Cole Cacciavillani would “transition out of their executive roles over the coming months.”
“Right now, our focus is on investors’ losses and whether the Company made statements about its business that, if untrue or incomplete, could have misled Aphria investors,” said Hagens Berman partner Reed Kathrein.
Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.